Submitted by Anonymous (not verified) on 7 November 2025 - 14:45
Human medicines European public assessment report (EPAR): Ahzantive, aflibercept, Date of authorisation: 13/01/2025, Revision: 4, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Ahzantive, aflibercept, Date of authorisation: 13/01/2025, Revision: 4, Status: Authorised